N. Miculinic (Zagreb, Croatia), M. Roberts (London, United Kingdom)
Late Breaking Abstract: A randomised, placebo controlled trial of 6 weeks‘ treatment with a novel oral p38 inhibitor in patients with COPD
W. MacNee, R. Allan, I. Jones, M. C. De Salvo, L. Tan (Edinburgh, Sandwich, United Kingdom; Buenos Aires, Argentina)
|  |
Roflumilast in the treatment of COPD: A pooled safety analysis
P. M. A. Calverley, L. M. Fabbri, K. F. Rabe, H. Mosberg (Liverpool, United Kingdom; Modena, Italy; , Netherlands; Konstanz, Germany)
| |
Effect of roflumilast (ROF) on glucose levels in patients with COPD and diabetes mellitus type 2 (DM2)
E. Wouters, P. Teichmann, M. Brose, L. Fabbri, K. Rabe (Netherlands; Konstanz, Germany; Modena, Italy)
| |
Efficacy of roflumilast in patients with a history of frequent exacerbations: Pooled data from pivotal 12-month studies
E. Bateman, P. M. A. Calverley, L. M. Fabbri, K. F. Rabe, S. I. Rennard, F. J. Martinez, U. M. Goehring (Cape Town, South Africa; Liverpool, United Kingdom; Modena, Italy; Leiden, Netherlands; Omaha, Ann Arbor, United States Of America; Konstanz, Germany)
| |
Immunomodulatory efficacy of inferon in chronic obstructive pulmonary disease
S. Farkhutdinov, U. Farkhutdinov (Ufa, Russian Federation)
| |
The effect of tiotropium in the treatment of patients with COPD
U. Farkhutdinov, S. Farkhutdinov, L. Oleinic (Ufa, Russian Federation)
|  |
The influence of tiotropium bromide on neutrophiles function of bronchial region in COPD patients
S. Fedosenko, G. Chernogoryuk, E. Roslyakova (Tomsk, Russian Federation)
| |
The improvement of the macrophages morphological characteristics in bronchial region in stable COPD patients under the influence of tiotropium bromide
S. Fedosenko, G. Chernogoryuk, E. Roslyakova, N. Kirillova (Tomsk, Russian Federation)
| |
Basic ways of tiotropium bromide‘s (TB) influence on mucociliary clearance (MCC)
T. Pertseva, O. Lykholat, O. Gurzhiy (Dnopropetrovs'k, Ukraine)
| |
Tiotropium for the treatment of stable chronic obstructive pulmonary disease: A meta-analysis of clinically relevant outcomes
A. Yohannes, T. Willgoss, J. Vestbo (United Kingdom)
| |
Effects of procaterol or salmeterol added to maintenance tiotropium therapy on small airway functions in COPD patients
N. Tanabe, S. Muro, T. Takahashi, H. Kiyokawa, M. Kudo, A. Haruna, S. Marumo, D. Kinose, M. Nishioka, Y. Hoshino, E. Ogawa, T. Hirai, M. Mishima (Fukui, Japan)
| |
The influence of fenspiride in complex therapy on quality of life in COPD patients
Y. Feshchenko, L. Iashyna, T. Pertseva, N. Monogarova, S. Ishchuk, L. Saveleva, I. Javad (Kiev, Dnepropetrovs'k, Donetsk, Ukraine)
| |
Use of non-steroid antiinflammatory therapy in COPD patients – Clinical effectiveness and influence on the physical tolerance
L. Iashyna, Y. Feshchenko, T. Pertseva, N. Monogarova, M. Polianska, S. Ishchuk, L. Saveleva (Kiev, Dnepropetrovs'k, Donetsk, Ukraine)
| |
Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease
T. Pertseva, O. Myronenko, N. Klimenko (Dnopropetrovs'k, Ukraine)
| |
Impact of statins, angiotensin-converting enzyme inhibitors(ACEI), and angiotensin receptor blockers (ARBs) on reducing COPD morbidity
N. Abdelaty (Ismailia, Egypt)
| |
Smoking, sputum cell counts, diffusion capacity and hyperinflation predict beneficial effects of long-term inhaled corticosteroids (ICS) on FEV1-decline in patients with mild-to-moderate COPD
J. B. Snoeck-Stroband, H. A. M. Kerstjens, T. S. Lapperre, H. M. Boezen, H. A. Thiadens, N. H. T. ten Hacken, W. Timens, P. S. Hiemstra, D. S. Postma, P. J. Sterk, J. K. Sont, Glucold Study Group (Groningen, Amsterdam, Netherlands)
| |
Audit of inhaled corticosteroid prescription in chronic obstructive pulmonary disease (COPD)
C. White, T. Yates, A. Oldroyd, S. Gompertz (United Kingdom)
| |
Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
M. Gertsen, A. Zhuiko, E. Atroshchenko (Minsk, Belarus)
| |
Management of stable COPD: Are GOLD recommendations fully applied?
F. Chermiti Ben Abdallah, S. Taktak, A. Chtourou, R. Mahouachi, A. Ben Kheder (Ariana, Tunisia)
| |
Validation and clinical application of a newly developed high-concentration oxygen-delivery device with a jet nebulizer function
K. Miyamoto, M. Takase, S. Fuke (Sapporo, Japan)
| |